FDA Adverse Event Malfunction Summary report: N

IVENIX, INC.

MDR report key: 20043232 · Received August 22, 2024

Report

Report Number
3014732157-2024-00589
Event Type
Malfunction
Date Received
August 22, 2024
Date of Event
August 5, 2024
Report Date
October 16, 2024
Manufacturer
FRESENIUS KABI USA LLC
Product Code
FPA
UDI-DI
00811505030054
PMA / PMN Number
K183311
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ID, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

SECTION D UPDATED TO ALIGN WITH THE INFORMATION LISTED ON GUDID.

Description of Event or Problem · 0

THE FOLLOWING HAS BEEN REPORTED: BIOMED REPORTED: FOUR PUMPS THAT STOPPED DURING INFUSIONS. PLEASE SEE LOGS AND EVALUATE. NO PATIENT HARM REPORTED AT THIS TIME. ISSUE OCCURRED WHILE USING LVP-0004 S/N (B)(6). A PRELIMINARY REVIEW OF THE LOGS IDENTIFIED THE FOLLOWING ISSUE: OVERINFUSION CONDITION (SAFE STATE 1) (SET ISSUE) AN ACTIVE INFUSION WAS STOPPED. REPORTING AS A CONSERVATIVE MEASURE. NO ADVERSE EFFECTS WERE REPORTED. ADDITIONAL INFORMATION IS NEEDED TO COMPLETE THE INVESTIGATION.

Description of Event or Problem · 0

NO PRODUCT WAS RETURNED AND NO LOT NUMBER WAS PROVIDED FOR EVALUATION. A CAPA WAS OPENED TO INVESTIGATE THE OVERINFUSION ALARMS AND A MANUFACTURING DEFECT FOR A SINGLE LOT WAS IDENTIFIED WHICH ALLOWED AN INTERNAL LEAK FROM ONE PORTION OF THE FLUID PATH TO ANOTHER. THE LOCATION OF THE LEAK BYPASSES THE FLUIDIC RESISTOR, AND THEREFORE THE "FLOW DIAL" IS UNABLE TO STOP THE FLOW OF FLUID WHEN OUTSIDE OF THE PUMP. THE LEAK RESULTS IN THE PUMP DECLARING ONE OF THE FOLLOWING 2 ALARMS: A) A "PUMP PROBLEM" FAIL-STOP ALARM (DUE TO OVER-INFUSION DETECTED BY CONTROL SYSTEM DURING INFUSION) B) A "TUBING SET PROBLEM" FAIL-STOP ALARM (DUE TO A LEAK DETECTED BY CONTROL SYSTEM DURING INFUSION) WHEN THE PUMP PROBLEM ALARM IS DECLARED, THE USER IS PROMPTED TO REMOVE THE ADMINISTRATION SET. IF THE USER EJECTS THE SET WITHOUT A SLIDE CLAMP ENGAGED THE LEAKAGE WILL CONTINUE. IF THE SET IS CONNECTED TO A PATIENT AT THE TIME, THE INFUSATE WILL CONTINUE TO BE DELIVERED TO THE PATIENT. THE INVESTIGATION WAS ABLE TO CONFIRM THAT A SINGLE LOT WAS AFFECTED DUE TO THIS MANUFACTURING DEFECT AS THE NEST ALIGNMENT ISSUE WAS ADDRESSED BEFORE THE PRODUCTION START OF THE NEXT LOT. THE MOST LIKELY ROOT CAUSE IDENTIFIED IS: INADEQUATE NEST LEVELING INSTALLATION CARRIED OUT AT CONTRACT MANUFACTURING SITE WHICH RESULTED IN A DEGRADED WELD QUALITY. ACTION PLANS HAVE BEEN DEVELOPED TO ENSURE PROPER NEST ALIGNMENT AND VERIFICATION VIA PROCEDURAL AND RMF UPDATES, TRAINING AND UPDATED LEAK TESTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1698440 IVENIX, INC. LVP PRIMARY ADMINISTRATION SET, DUAL-INLET, LOW-SORBING, NEEDLE-FREE PORT, Y-SIT FPA FRESENIUS KABI USA LLC SET-0013-1 00811505030054

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown